| Title | Date | PubMed ID |
|---|
| Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models. | 2012 Sep | 22068166 |
| In Vitro Selection of Cathepsin E-Activity-Enhancing Peptide Aptamers at Neutral pH. | 2011 | 21527983 |
| Selective detection of Cathepsin E proteolytic activity. | 2010 Sep | 20600629 |
| Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis. | 2010 Aug | 20482316 |
| Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation. | 2009 Sep 24 | 19715320 |
| Impaired chemotaxis and cell adhesion due to decrease in several cell-surface receptors in cathepsin E-deficient macrophages. | 2009 May | 19174547 |
| Development of systemic in vitro evolution and its application to generation of peptide-aptamer-based inhibitors of cathepsin E. | 2009 Apr 17 | 19150354 |
| Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. | 2009 Mar | 19172291 |
| Meloidogyne incognita: molecular cloning and characterization of a cDNA encoding a cathepsin D-like aspartic proteinase. | 2009 Feb | 18952081 |
| Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells. | 2008 Dec 26 | 18996084 |